Presence Of Cancer-Associated Fibroblasts Inversely Correlates With Schwannian Stroma In Neuroblastoma Tumors
暂无分享,去创建一个
Yufeng Tian | Qiwei Yang | S. Cohn | Susan L Cohn | Qiwei Yang | R. Zeine | A. Chlenski | H. Salwen | Alexandre Chlenski | Helen R Salwen | Radhika Peddinti | Lisa Guerrero | Rana Zeine | Yufeng Tian | L. Guerrero | R. Peddinti
[1] A. Look,et al. Detection of MYCN gene amplification in neuroblastoma by fluorescence in situ hybridization: a pediatric oncology group study. , 2001, Neoplasia.
[2] G. Watkins,et al. The HGF/SF antagonist NK4 reverses fibroblast‐ and HGF‐induced prostate tumor growth and angiogenesis in vivo , 2003, International journal of cancer.
[3] Giulio Gabbiani,et al. The stroma reaction myofibroblast: a key player in the control of tumor cell behavior. , 2004, The International journal of developmental biology.
[4] A. Ostman,et al. Tumour-stroma interaction: cancer-associated fibroblasts as novel targets in anti-cancer therapy? , 2004, Lung cancer.
[5] Zhang Weidong,et al. Clinicopathological Significance of Stromal Myofibroblasts in Invasive Ductal Carcinoma of the Breast , 2004, Tumor Biology.
[6] A. Nakagawara,et al. Prognostic VaIue of N‐myc Oncogene Amplification and S‐100 Protein Positivity in Children with Neuroblastic Tumors , 1992, Acta pathologica japonica.
[7] S. Cohn,et al. SPARC enhances tumor stroma formation and prevents fibroblast activation , 2007, Oncogene.
[8] J. Bowen,et al. Protocol for the examination of specimens from patients with neuroblastoma and related neuroblastic tumors. , 2005, Archives of pathology & laboratory medicine.
[9] K. Matsumoto,et al. Induction of hepatocyte growth factor in fibroblasts by tumor-derived factors affects invasive growth of tumor cells: in vitro analysis of tumor-stromal interactions. , 1997, Cancer research.
[10] Qiwei Yang,et al. Cross-talk between Schwann cells and neuroblasts influences the biology of neuroblastoma xenografts. , 2005, The American journal of pathology.
[11] K. Cole,et al. Prominent Microvascular Proliferation in Clinically Aggressive Neuroblastoma , 2007, Clinical Cancer Research.
[12] Hiroyuki Shimada,et al. Terminology and morphologic criteria of neuroblastic tumors , 1999, Cancer.
[13] Qiwei Yang,et al. Methylation-associated silencing of the thrombospondin-1 gene in human neuroblastoma. , 2003, Cancer research.
[14] H. B. Marsden,et al. Histopathologic prognostic factors in neuroblastic tumors: definition of subtypes of ganglioneuroblastoma and an age-linked classification of neuroblastomas. , 1984, Journal of the National Cancer Institute.
[15] Olivier De Wever,et al. Role of tissue stroma in cancer cell invasion , 2003, The Journal of pathology.
[16] O. Volpert,et al. Pigment epithelium-derived factor (PEDF) in neuroblastoma: a multifunctional mediator of Schwann cell antitumor activity. , 2001, Journal of cell science.
[17] Raghu Kalluri,et al. Fibroblasts in cancer , 2006, Nature Reviews Cancer.
[18] W. Frankel,et al. Role of cancer-associated stromal fibroblasts in metastatic colon cancer to the liver and their expression profiles , 2004, Oncogene.
[19] J. Nesland,et al. Activation of EDTA-resistant gelatinases in malignant human tumors. , 2006, Cancer research.
[20] K K Matthay,et al. The International Neuroblastoma Pathology Classification (the Shimada system) , 1999, Cancer.
[21] O. Petersen,et al. Smooth muscle differentiation in cultured human breast gland stromal cells. , 1990, Laboratory investigation; a journal of technical methods and pathology.
[22] M. A. Huber,et al. Fibroblast activation protein: differential expression and serine protease activity in reactive stromal fibroblasts of melanocytic skin tumors. , 2003, The Journal of investigative dermatology.
[23] T. Nakamura,et al. Growth and angiogenesis of human breast cancer in a nude mouse tumour model is reduced by NK4, a HGF/SF antagonist. , 2003, Carcinogenesis.
[24] J. Park,et al. Fibroblast Activation Protein, a Dual Specificity Serine Protease Expressed in Reactive Human Tumor Stromal Fibroblasts* , 1999, The Journal of Biological Chemistry.
[25] Webster K. Cavenee,et al. Pathology and genetics of tumours of the nervous system. , 2000 .
[26] O. Volpert,et al. SPARC is a key Schwannian-derived inhibitor controlling neuroblastoma tumor angiogenesis. , 2002, Cancer research.
[27] E. Ross,et al. Clinical Implications of Fibroblast Activation Protein in Patients with Colon Cancer , 2007, Clinical Cancer Research.
[28] L. Orci,et al. Alpha-smooth muscle actin, a differentiation marker of smooth muscle cells, is present in microfilamentous bundles of pericytes. , 1989, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.
[29] C. R. Pinkerton,et al. International criteria for diagnosis, staging and response to treatment in patients with neuroblastoma. , 1988, Progress in clinical and biological research.
[30] Dennis C. Sgroi,et al. Stromal Fibroblasts Present in Invasive Human Breast Carcinomas Promote Tumor Growth and Angiogenesis through Elevated SDF-1/CXCL12 Secretion , 2005, Cell.
[31] A. Rademaker,et al. Tumor angiogenesis correlates with metastatic disease, N-myc amplification, and poor outcome in human neuroblastoma. , 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[32] M. Tsuneyoshi,et al. S-100 positive undifferentiated neuroblastomas with a special reference to the tumor stroma related to favorable prognosis. , 1992, Pathology, research and practice.
[33] G. Ayala,et al. Stromal cells promote angiogenesis and growth of human prostate tumors in a differential reactive stroma (DRS) xenograft model. , 2002, Cancer research.
[34] G. Ayala,et al. Reactive stroma in human prostate cancer: induction of myofibroblast phenotype and extracellular matrix remodeling. , 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.
[35] Mark W. Kieran,et al. Identification of fibroblast heterogeneity in the tumor microenvironment , 2006, Cancer biology & therapy.
[36] A. Rojiani,et al. Glomeruloid vascular structures in glioblastoma multiforme: an immunohistochemical and ultrastructural study. , 1996, Journal of neurosurgery.